A two-year randomized controlled trial reported that perioperative denosumab preserved systemic bone density in older adults undergoing primary total knee arthroplasty. The results were framed around preservation of lumbar spine and femoral neck bone density following surgery and perioperative care. By demonstrating measurable density maintenance over a prolonged follow-up window, the study adds evidence for how antiresorptive therapy can complement surgical management in an elderly population at risk for post-surgical skeletal decline. The trial supports continued exploration of dosing timing and duration for denosumab as an adjunct to orthopedic interventions, with the central endpoint being maintenance of clinically meaningful bone compartments.
Get the Daily Brief